A detailed history of Midwest Professional Planners, Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Midwest Professional Planners, Ltd. holds 10,140 shares of IONS stock, worth $384,407. This represents 0.16% of its overall portfolio holdings.

Number of Shares
10,140
Previous 9,716 4.36%
Holding current value
$384,407
Previous $421,000 14.73%
% of portfolio
0.16%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$36.45 - $47.7 $15,454 - $20,224
424 Added 4.36%
10,140 $483,000
Q1 2024

May 09, 2024

BUY
$42.03 - $53.55 $50,309 - $64,099
1,197 Added 14.05%
9,716 $421,000
Q4 2023

Feb 15, 2024

BUY
$43.39 - $51.63 $30,112 - $35,831
694 Added 8.87%
8,519 $430,000
Q3 2023

Nov 13, 2023

BUY
$38.5 - $47.13 $47,432 - $58,064
1,232 Added 18.69%
7,825 $354,000
Q2 2023

Aug 07, 2023

BUY
$34.73 - $43.33 $228,974 - $285,674
6,593 New
6,593 $270,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.38B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Midwest Professional Planners, Ltd. Portfolio

Follow Midwest Professional Planners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.